These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22001088)

  • 1. The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase.
    Bromba CM; Mason JW; Brant MG; Chan T; Lunke MD; Petric M; Boulanger MJ; Wulff JE
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7137-41. PubMed ID: 22001088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peramivir Phosphonate Derivatives as Influenza Neuraminidase Inhibitors.
    Wang PC; Fang JM; Tsai KC; Wang SY; Huang WI; Tseng YC; Cheng YS; Cheng TJ; Wong CH
    J Med Chem; 2016 Jun; 59(11):5297-310. PubMed ID: 27167096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peramivir analogues bearing hydrophilic side chains exhibit higher activities against H275Y mutant than wild-type influenza virus.
    Chiu DC; Lin TC; Huang WI; Cheng TJ; Tsai KC; Fang JM
    Org Biomol Chem; 2017 Nov; 15(46):9910-9922. PubMed ID: 29159346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.
    Babu YS; Chand P; Bantia S; Kotian P; Dehghani A; El-Kattan Y; Lin TH; Hutchison TL; Elliott AJ; Parker CD; Ananth SL; Horn LL; Laver GW; Montgomery JA
    J Med Chem; 2000 Sep; 43(19):3482-6. PubMed ID: 11000002
    [No Abstract]   [Full Text] [Related]  

  • 5. Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
    Udommaneethanakit T; Rungrotmongkol T; Bren U; Frecer V; Stanislav M
    J Chem Inf Model; 2009 Oct; 49(10):2323-32. PubMed ID: 19780597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.
    Fujisaki S; Takashita E; Yokoyama M; Taniwaki T; Xu H; Kishida N; Sato H; Tashiro M; Imai M; Odagiri T
    Biochem Biophys Res Commun; 2012 Dec; 429(1-2):51-6. PubMed ID: 23131559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K.
    Tran-To Su C; Ouyang X; Zheng J; Kwoh CK
    BMC Bioinformatics; 2013; 14 Suppl 16(Suppl 16):S7. PubMed ID: 24564719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].
    Reina J
    Rev Esp Quimioter; 2006 Dec; 19(4):317-22. PubMed ID: 17235399
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities.
    Lin CH; Chang TC; Das A; Fang MY; Hung HC; Hsu KC; Yang JM; von Itzstein M; Mong KK; Hsu TA; Lin CC
    Org Biomol Chem; 2013 Jun; 11(24):3943-8. PubMed ID: 23695381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
    Malaisree M; Rungrotmongkol T; Decha P; Intharathep P; Aruksakunwong O; Hannongbua S
    Proteins; 2008 Jun; 71(4):1908-18. PubMed ID: 18175324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme.
    Bantia S; Upshaw R; Babu YS
    Antiviral Res; 2011 Sep; 91(3):288-91. PubMed ID: 21722670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir.
    Baz M; Abed Y; Boivin G
    Antiviral Res; 2007 May; 74(2):159-62. PubMed ID: 17137644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peramivir conjugates as orally available agents against influenza H275Y mutant.
    Wang PC; Chiu DC; Jan JT; Huang WI; Tseng YC; Li TT; Cheng TJ; Tsai KC; Fang JM
    Eur J Med Chem; 2018 Feb; 145():224-234. PubMed ID: 29324342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
    Smith PW; Sollis SL; Howes PD; Cherry PC; Starkey ID; Cobley KN; Weston H; Scicinski J; Merritt A; Whittington A; Wyatt P; Taylor N; Green D; Bethell R; Madar S; Fenton RJ; Morley PJ; Pateman T; Beresford A
    J Med Chem; 1998 Mar; 41(6):787-97. PubMed ID: 9526555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity.
    Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin TH; Hutchison TL; Babu YS; Bantia S; Elliott AJ; Montgomery JA
    J Med Chem; 2001 Dec; 44(25):4379-92. PubMed ID: 11728184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir.
    Liu KC; Lee PS; Wang SY; Cheng YS; Fang JM; Wong CH
    Bioorg Med Chem; 2011 Aug; 19(16):4796-802. PubMed ID: 21778065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The model of prediction of the inhibition of neuraminidases of influenza A and B based on a reduced set of energy terms].
    Mikurova AV; Skvortsov VS
    Biomed Khim; 2019 Oct; 65(6):520-525. PubMed ID: 31876523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peramivir binding affinity with influenza A neuraminidase and research on its mutations using an induced-fit docking approach.
    Tran-Nguyen VK; Le MT; Tran TD; Truong VD; Thai KM
    SAR QSAR Environ Res; 2019 Dec; 30(12):899-917. PubMed ID: 31645133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.